OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
601216$5.3756

601216.SS

Commodity ChemicalsVerified

The company maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.21, indicating a conservative leverage position compared to the industry median. Its liquidity position is characterized by a current ratio of 1.3, suggesting moderate short-term liquidity. The company's price-to-book ratio of 1.55 and price-to-tangible-book ratio of 1.55 indicate that the market values the company at a premium to its book value, but not excessively so. Free cash flow of 3.47 billion CNY supports operational flexibility and potential for shareholder returns. Profitability metrics show a return on equity (ROE) of 11.33% and a return on assets (ROA) of 7.88%, both of which are strong indicators of efficient capital use and asset management. These figures are in line with the industry's preferred metrics, which emphasize ROIC and ROA as key performance indicators. The company's gross profit margin of 20.5% and operating margin of 14.5% are consistent with the industry's expectations for cost control and operational efficiency. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue breakdowns in the financial data limits the ability to assess the performance of individual product lines or geographic regions. The company's growth trajectory is expected to remain stable, with no significant revenue growth projected in the current or next fiscal year. Historical revenue data shows a consistent but modest growth rate, and the outlook for the next fiscal year is neutral. The company's capital expenditure of -1.04 billion CNY suggests a reduction in investment, which may indicate a focus on cost optimization rather than expansion. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. This could limit its ability to meet short-term obligations without additional financing. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's financial structure and conservative leverage position reduce the likelihood of near-term dilution. Recent events include the publication of the latest financial report, which provides updated financial metrics and operational performance. No significant corporate actions or regulatory changes have been disclosed in the recent filings. The company's financial health and operational performance remain stable, with no immediate threats to its market position.

30-day price · 601216-0.40 (-7.2%)
Low$5.08High$5.75Close$5.13As of28 May, 00:00 UTC
Profile
Company601216.SS
Ticker601216.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

The company maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.21, indicating a conservative leverage position compared to the industry median. Its liquidity position is characterized by a current ratio of 1.3, suggesting moderate short-term liquidity. The company's price-to-book ratio of 1.55 and price-to-tangible-book ratio of 1.55 indicate that the market values the company at a premium to its book value, but not excessively so. Free cash flow of 3.47 billion CNY supports operational flexibility and potential for shareholder returns. Profitability metrics show a return on equity (ROE) of 11.33% and a return on assets (ROA) of 7.88%, both of which are strong indicators of efficient capital use and asset management. These figures are in line with the industry's preferred metrics, which emphasize ROIC and ROA as key performance indicators. The company's gross profit margin of 20.5% and operating margin of 14.5% are consistent with the industry's expectations for cost control and operational efficiency. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue breakdowns in the financial data limits the ability to assess the performance of individual product lines or geographic regions. The company's growth trajectory is expected to remain stable, with no significant revenue growth projected in the current or next fiscal year. Historical revenue data shows a consistent but modest growth rate, and the outlook for the next fiscal year is neutral. The company's capital expenditure of -1.04 billion CNY suggests a reduction in investment, which may indicate a focus on cost optimization rather than expansion. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. This could limit its ability to meet short-term obligations without additional financing. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's financial structure and conservative leverage position reduce the likelihood of near-term dilution. Recent events include the publication of the latest financial report, which provides updated financial metrics and operational performance. No significant corporate actions or regulatory changes have been disclosed in the recent filings. The company's financial health and operational performance remain stable, with no immediate threats to its market position.
Key takeaways
  • The company maintains a conservative debt-to-equity ratio of 0.21, indicating a strong capital structure.
  • Return on equity of 11.33% and return on assets of 7.88% demonstrate efficient use of capital and assets.
  • The company's liquidity position is moderate, with a current ratio of 1.3 and a price-to-book ratio of 1.55.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Growth is expected to remain stable, with no significant revenue growth projected in the current or next fiscal year.
  • The company's risk profile is characterized by medium liquidity risk and low dilution risk.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$25.24B
Gross profit$5.17B
Operating income$3.67B
Net income$3.32B
R&D
SG&A
D&A
SBC
Operating cash flow$5.17B
CapEx-$1.04B
Free cash flow$3.47B
Total assets$42.09B
Total liabilities$12.81B
Total equity$29.27B
Cash & equivalents
Long-term debt$6.08B
Valuation
Market price$5.37
Market cap$45.31B
Enterprise value$51.39B
P/E13.7
Reported non-GAAP P/E
EV/Revenue2.0
EV/Op income14.0
EV/OCF9.9
P/B1.6
P/Tangible book1.6
Tangible book$29.27B
Net cash-$6.08B
Current ratio1.3
Debt/Equity0.2
ROA7.9%
ROE11.3%
Cash conversion1.6%
CapEx/Revenue-4.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric601216Activity
Op margin14.6%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin13.1%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin20.5%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-4.1%-6.2% medp25 -13.4% · p75 -2.6%above median
Debt / equity21.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 18:17 UTC#28b11079
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:49 UTCJob: e4ab83a6